A rapid, sensitive and specific radioimmunoassay for methotrexate
- PMID: 912922
- DOI: 10.1016/0009-8981(77)90151-6
A rapid, sensitive and specific radioimmunoassay for methotrexate
Abstract
A rapid, sensitive, radioimmunoassay for methotrexate has been developed using tritiated methotrexate and an antiserum raised in rabbits against the immunogen, bovine serum albumin containing 34 methotrexate residues per protein molecule. Separation of bound and free drug was attained using donkey anti-rabbit precipitating serum. The method can accurately measure as little as 50 fmol methotrexate in capillary blood samples and is not interfered with by vast excesses of natural folates nor citrovorum rescue factor. The method can handle 30 samples per day with the results available after 6 h. This makes it suitable for monitoring serum methotrexate levels after high dose therapy when a result is required within 24 h to provide helpful information regarding impending toxicity and the need for extended citrovorum rescue factor or maintenance of urinary pH.
Similar articles
-
Rapid radioimmunoassay for methotrexate in biological fluids.Clin Chem. 1976 Jun;22(6):813-6. Clin Chem. 1976. PMID: 945138
-
A fully automated, continuous-flow radioimmunoassay for methotrexate.Clin Chem. 1980 Jan;26(1):97-100. Clin Chem. 1980. PMID: 7356581
-
A rapid and specific radioimmunoassay for methotrexate.Cancer Res. 1975 Jun;35(6):1407-10. Cancer Res. 1975. PMID: 1079473
-
Evaluation of enzyme immunoassay, radioassay, and radioimmunoassay of serum methotrexate, as compared with liquid chromatography.Clin Chem. 1980 Dec;26(13):1902-4. Clin Chem. 1980. PMID: 7002366
-
Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.Ther Drug Monit. 1980;2(2):177-85. Ther Drug Monit. 1980. PMID: 6762711 Review.
Cited by
-
Bioavailability of methotrexate: implications for clinical use.Cancer Chemother Pharmacol. 1979;3(4):239-41. doi: 10.1007/BF00254738. Cancer Chemother Pharmacol. 1979. PMID: 535133
-
Serum, tear and salivary concentrations of methotrexate in man.Br J Clin Pharmacol. 1979 Feb;7(2):207-11. doi: 10.1111/j.1365-2125.1979.tb00923.x. Br J Clin Pharmacol. 1979. PMID: 760754 Free PMC article.
-
An indication of possible impending toxicity during moderately high dose methotrexate infusions.Br J Clin Pharmacol. 1978 Dec;6(6):551-2. doi: 10.1111/j.1365-2125.1978.tb00887.x. Br J Clin Pharmacol. 1978. PMID: 569491 Free PMC article. No abstract available.
-
Enhancement of methotrexate absorption by subdivision of dose.Cancer Chemother Pharmacol. 1979;3(4):235-7. doi: 10.1007/BF00254737. Cancer Chemother Pharmacol. 1979. PMID: 535132 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources